Facebook
Twitter
LinkedIn
Forward
Innovations in breast oncology can translate to improved patient outcomes for patients with early and late-stage disease. In this webinar, Dr. Ray will discuss the latest research findings and how they can be translated into the clinical care of patients with breast cancer.
|
Cancer patients and survivors have higher rates of anxiety and depression compared to the general population. Cancer-related anxiety and depression may significantly reduce wellbeing and result in adverse treatment and survival outcomes. This lecture will provide an overview of psychotherapeutic modalities that can treat cancer-related distress.
|
Joe Polich, MSW, LCSWA, JD will provide a foundational knowledge to providers who come in contact with patients with cancer who are also experiencing IPV. Beginning with a quick introduction to some basic concepts of the dynamics of IPV in general, we will discuss the intersection of the provision of care to a patient with cancer and the dynamics involved in IPV.
|
Yuri Fedoriw, MD, provides a general background of cancer pathology and tissue diagnosis. The development of testing methods and their application will be discussed, as will the limitations and challenges of cancer classification.
|
Zev Nakamura, MD will present on key topics related to cognitive issues experienced by patients with cancer.
|
Lauren Lux, MSW and Melissa Matson, MSN, RN, AGPCNP-BC and Catharine Swift, MSW, LCSW highlight tools and strategies that healthcare providers can deploy to meet the medical and psychosocial needs of the AYAs in their care.
|
Sonali Acharya, PharmD. will explain the role of specialty pharmacies. We will discuss accreditation requirements for specialty pharmacies, process to determine which medications are considered specialty and specifically the benefits of a healthcare system specialty pharmacy.
|
Symptom burden is high in thoracic surgery and oncology patients. Gita Mody, MD, MPH discusses the role of electronic patient-reported outcome (ePRO) remote monitoring systems to improve patients' survivorship care.
|
William Wood, MD, MPH will review ways to expand traditional clinic-based cancer navigation to population-based cancer navigation using a central navigation approach. We will discuss how this approach can foster equity in care delivery and outcomes, while incorporating new initiatives that promote quality improvement. We will also talk about how this work fits into the current national environment that surrounds cancer navigation, including the recent development of a learning community and of new proposed billing codes that support the delivery of navigation services.
|
Puneet Singh Jolly, MD, PhD discusses keratinocyte neoplasms are by far the most common malignancy in the world. While surgical treatments remain the most common and most effective therapy, there are numerous emerging non-surgical techniques. We discuss these and the rationale for using such treatments, particularly in specific challenging clinical scenarios.
|